Using its ZymTrap™system, Zymtronix has demonstrated 98% retained activity of a magnetically-immobilized nitrilase relative to its free counterpart, specifically for the nicotinic acid producing... View Article
Zymtronix recently demonstrated 101% retained activity of bovine carbonic anhydrase immobilized on its ZymTrap™ platform relative to free counterpart. Read the full... View Article
In an effort to capitalize on the industrial usefulness of ω-transaminase, Zymtronix has demonstrated 100% retained activity of magnetically-immobilized ω-transaminase relative to... View Article
Using its ZymTrap™ system, Zymtronix has demonstrated 160% activity of a magnetically-immobilized peroxidase relative to its free counterpart. Read the... View Article
27th August 2020 – Ithaca, NY – Zymtronix, developer of revolutionary immobilization and process technologies for enzyme applications, has appointed a new member to its Board of Managers.
4 February 2020 – Ithaca, NY and London, UK – Zymtronix, developer of revolutionary enzyme immobilization technologies, and Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, today announced a new partnership.
